Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role
How long will it take to achieve my goals
[] In late 2024, the ongoing Phase III ESSENCE trial (NCT04822181) assessing once-weekly 2.4 mg semaglutide in adults with MASH and moderate to advanced liver fibrosis (F2F3) revealed fibrosis improvement without worsening steatohepatitis in 37% of patients receiving semaglutide, compared to 22.5% in the placebo group, with an estimated difference in the proportion of responders (EDP) of 14.4%, making it the first study which confirmed semaglutides efficacy in improving liver fibrosis
Under the electron microscope, mild mitochondrial swelling, increased volume, local fragmentation and reduction of cristae, and local dissolution of the intramembrane matrix, and mitochondrial micro-autonomy can be seen in the visual field
To whom it may concern its still too early to tell if those injections are working
References Costell M, et al